| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/153331750201700104 |
| P698 | PubMed publication ID | 11831417 |
| P2093 | author name string | Bernadette Kalman | |
| Eduardo Adonias DeSousa | |||
| Ross H Albert | |||
| P2860 | cites work | Defining the clinical course of multiple sclerosis: Results of an international survey | Q22241638 |
| APOE genotype is a major predictor of long-term progression of disability in MS | Q28199870 | ||
| Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction | Q28276538 | ||
| A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 | Q28283861 | ||
| Cause of death in patients attending multiple sclerosis clinics | Q28288701 | ||
| A serial study of new MS lesions and the white matter from which they arise | Q28291585 | ||
| Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group | Q28293763 | ||
| Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination | Q29614990 | ||
| Assessment of the damage of the cerebral hemispheres in MS using neuroimaging techniques | Q30585738 | ||
| Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI. | Q30587288 | ||
| Spectrum and classification of inflammatory demyelinating diseases of the central nervous system | Q30680066 | ||
| Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup? | Q33179184 | ||
| SPECT, MRI and cognitive functions in multiple sclerosis | Q33589282 | ||
| Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions | Q33946231 | ||
| Genomewide scan of multiple sclerosis in Finnish multiplex families | Q35250139 | ||
| Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis | Q35455319 | ||
| Neuropsychological deficits in multiple sclerosis after acute relapse | Q36318073 | ||
| Neuropsychologic status in multiple sclerosis after treatment with glatiramer | Q38450118 | ||
| The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen | Q40837236 | ||
| Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force | Q40881098 | ||
| A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments | Q42627062 | ||
| Interferon beta 1-b in verbal memory functioning of patients with relapsing-remitting multiple sclerosis | Q46200872 | ||
| A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). | Q48160545 | ||
| Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis | Q48162389 | ||
| Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis | Q48180186 | ||
| Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis. | Q48314477 | ||
| Clinical significance of reduced cerebral metabolism in multiple sclerosis: a combined PET and MRI study | Q48442549 | ||
| Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis | Q48444625 | ||
| Neuropsychological and structural brain lesions in multiple sclerosis: A regional analysis | Q48459002 | ||
| Imaging axonal damage of normal-appearing white matter in multiple sclerosis | Q48486976 | ||
| Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study | Q49029566 | ||
| Patterns of cognitive impairment in secondary progressive stable phase of multiple sclerosis: correlations with MRI findings. | Q49096364 | ||
| Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI). | Q52017301 | ||
| Cognitive functioning and depression in patients with chronic fatigue syndrome and multiple sclerosis. | Q52025126 | ||
| The Brief Repeatable Battery of Neuropsychological Tests for Multiple Sclerosis: a preliminary serial study. | Q52050963 | ||
| Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. | Q52051437 | ||
| Magnetic resonance imaging correlates of dementia in multiple sclerosis. | Q52130347 | ||
| Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate | Q53501154 | ||
| A full genome search in multiple sclerosis | Q57264092 | ||
| Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis | Q57912405 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple sclerosis | Q8277 |
| cognitive dysfunction | Q57859955 | ||
| P304 | page(s) | 23-29 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | American Journal of Alzheimer's Disease & Other Dementias | Q4744232 |
| P1476 | title | Cognitive impairments in multiple sclerosis: a review | |
| P478 | volume | 17 |
| Q37849769 | Cognitive and neurobehavioral features in multiple sclerosis |
| Q48553216 | Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study |
| Q48868475 | Depression, disability and cognitive impairment in multiple sclerosis: a cross sectional Italian study |
| Q48022617 | Different types of exercise in Multiple Sclerosis: Aerobic exercise or Pilates, a single-blind clinical study |
| Q24794380 | Effect of pioglitazone treatment in a patient with secondary multiple sclerosis |
| Q46800339 | Effects of high-dose cortisone therapy on cognition |
| Q36031826 | Exercise in multiple sclerosis -- an integral component of disease management |
| Q44072358 | Fatigue and cognition in patients with relapsing multiple sclerosis treated with interferon β. |
| Q50789813 | Impact of the cognitive status on the memory complaints in MS patients. |
| Q48238381 | Increased risk of dementia among chronic osteomyelitis patients |
| Q36822094 | Influences on cognition by immunosuppression and immunomodulation in multiple sclerosis |
| Q51973745 | Internet-based cognitive testing in multiple sclerosis. |
| Q38411547 | Memory interference in multiple sclerosis |
| Q37328815 | Multiple sclerosis and reproductive risks in women |
| Q81486800 | Neuroimaging in multiple sclerosis |
| Q36474339 | Neuropsychiatric manifestations of multiple sclerosis. |
| Q45079644 | Nursing home residents with multiple sclerosis and dementia compared to other multiple sclerosis residents |
| Q50592731 | Ocular motor measures of cognitive dysfunction in multiple sclerosis II: working memory. |
| Q57498077 | Performance of activities of daily living in multiple sclerosis |
| Q34975609 | Prospective memory and chronic heart failure |
| Q47755455 | Prospective memory impairment in multiple sclerosis: a review |
| Q51976048 | Prospective memory in multiple sclerosis. |
| Q50584103 | Prospective memory, emotional valence, and multiple sclerosis. |
| Q46578786 | Quality and quantity of diffuse and focal white matter disease and cognitive disability of patients with multiple sclerosis |
| Q51904830 | Rapid cognitive screening in multiple sclerosis accomplished by the Free Recall and Recognition Test. |
| Q51887119 | Relationship of cognitive impairment to psychiatric symptoms in multiple sclerosis. |
| Q35018491 | Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice |
| Q35476266 | Working memory deficits in multiple sclerosis: a controlled study with auditory P600 correlates |
| Q35518978 | Young onset dementia |
Search more.